TAT-GluR23A Fusion Peptide – 1 mg

Overview

The TAT-GluR23A Fusion Peptide is a carefully designed control inactive peptide that serves as a mutant counterpart to the glutamate receptor endocytosis inhibitor, GluR23Y. This fusion peptide incorporates an 11 amino acid HIV Trans-Activator of Transcription (TAT) protein transduction domain (PTD), allowing it to permeate cell membranes efficiently. The sequence is derived from GluR23Y amino acids 869 to 877, with alanine substituting for tyrosine, resulting in a formulation that lacks essential phosphorylation sites. You can purchase the TAT-GluR23A Fusion Peptide from AnaSpec today and facilitate your research with a reliable tool for studying glutamate receptor activity.

Key Features

• Control inactive peptide for GluR23Y studies
• 11 amino acid TAT protein transduction domain enhances permeability
• Precise substitution of alanine for tyrosine
• Ideal for research applications in neuroscience

Specifications

FAQ

What is the purpose of the TAT-GluR23A Fusion Peptide?

This peptide functions as a control for studies involving GluR23Y, helping researchers understand glutamate receptor dynamics without the influence of active phosphorylation sites.

How should I store the TAT-GluR23A Fusion Peptide?

It’s best to store this peptide at -20°C to maintain its stability and effectiveness over time.

Can I use this peptide for in vitro experiments?

Yes, the TAT-GluR23A Fusion Peptide is suitable for in vitro experiments involving cell culture and receptor studies, particularly in the context of neuroscience research.

To amplify your research, explore our PKG Substrate or check out the Autocamtide-2. The TAT-GluR23A Fusion Peptide is an invaluable addition to your toolkit for protein studies and receptor research. Order now from AnaSpec and enhance your experiments with high-quality peptides.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.